Drugs & medicalClass II

Instrumentation Laboratory recalls HemosIL ReadiPlasTin, Part No. 0020301400

Variable and out of specification QC results with HemosIL ReadiPlasTin. IL will remove all lots from the market and convert customers to an alternative prothrombin time (PT) reagent, specifically HemosIL RecombiPlasTin…

Read the official notice →
Date
2022-05-18
Country
United States
Brand
Instrumentation Laboratory
Product
HemosIL ReadiPlasTin, Part No. 0020301400
Classification
Class II
Units
US Nationwide distribution including in the states of AZ, CA, IA, IL, IN, KS,…
Category
Drugs & medical
Source
FDA · Device

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Instrumentation Laboratory recalls

  1. 2023-11-29
  2. US
    Drugs & medicalClass II

    Instrumentation Laboratory recalls GEM Premier 3000 PAK - pH, pCO2, pO2, Hct, Na+, K+, Ca++, Part Numbers 00024307507, 00024315007, 00024330007, 00024345007, 00024360007

    Internal testing identified that the GEM Premier PAKs (cartridges) may exhibit an over-recovery (i.e., positive bias) of pO2 results in the low range (at pO2 levels less than 60 mmHg) that are outside of labeled…

    FDA · DeviceInstrumentation LaboratoryUS States: MA, MN, NY. India.Official notice →
  3. 2023-09-20
  4. US
    Drugs & medicalClass II

    Instrumentation Laboratory recalls ACL TOP Family 50 Series Models as follows: In vitro diagnostic clinical use in the hemostasis laboratory for coagulation and/or…

    Sample misidentification could occur under specific conditions and patient management altered based on an incorrectly assigned result

    FDA · DeviceInstrumentation LaboratoryWorldwide distribution - US Nationwide and the countries of Canada, Finland,…Official notice →
  5. 2023-04-05
  6. US
    Drugs & medicalClass II

    Instrumentation Laboratory recalls ACL ELITE Refurbished-Analyzer designed specifically for clinical use in the hemostasis laboratory, for coagulation and/or…

    Removes the test definition for HemosIL Liquid Anti-Xa (PN 0020302600 and 0020302601) from the ACL Elite/Elite Pro instruments

    FDA · DeviceInstrumentation LaboratoryWorldwide distribution - US Nationwide and the countries of Canada, Albania,…Official notice →
  7. 2022-05-04
  8. US
    Drugs & medicalClass II

    Instrumentation Laboratory recalls ACL TOP 300 CTS/350 CTS/500 CTS/550 CTS/970 CL: Name Part Number 1.ACL TOP 300 CTS 00000280060 2. ACL TOP 300 CTS 00000280060R…

    Updated and revised user instructions issued 7/14/22. Potential carryover issue may cause elevated quality control and sample results for heparin, apixaban or rivaroxaban when HemosIL Liquid Anti-Xa reagent is used in…

    FDA · DeviceInstrumentation LaboratoryWorldwide distribution - US Nationwide and the countries of Argentina,…Official notice →
  9. 2021-12-01
  10. US
    Drugs & medicalClass II

    Instrumentation Laboratory recalls HemosIL ReadiPlasTin (20 mL), Part number 0020301400. An in vitro diagnostic thromboplastin reagent.

    The firm has received customer reports of performance issues with the affected lot, including increased imprecision, out of range quality controls, and prolonged sample results. If quality controls are not performed or…

    FDA · DeviceInstrumentation LaboratoryWorldwide distribution - US Nationwide distribution in the states of AZ, CA,…Official notice →
  11. 2021-10-27
  12. US
    Drugs & medicalClass II

    Instrumentation Laboratory recalls HemosIL Liquid Anti-Xa- Automated chromogenic assay for the quantitative determination of unfractionated heparin (UFH) and low…

    Labeled On-board instrument stability issue for current and future lots, reduced On-board Instrument Stability from 7 days to 5 days

    FDA · DeviceInstrumentation LaboratoryUS Nationwide Foreign: Canada Armenia Austria Australia Belgium Brunei Brazil…Official notice →
All 14 Instrumentation Laboratory recalls →

Other drugs & medical recalls in the United States

  1. 2022-05-18
  2. US
    Drugs & medicalClass III

    Cerapedics, Inc. recalls putty i-FACTOR Peptide Enhanced Bone Graft 1.0cc Syringe REF 700-010, PUTTY

    Patient chart label contains incorrect Part Number and volume amount.

    FDA · DeviceCerapedics, Inc.U.S. Nationwide distribution in the states of AL, AZ, CA, CT, DC, DE, ID, IN,…Official notice →
  3. US
    Drugs & medicalClass II

    Karl Storz Endoscopy recalls 11005BC1 11005BCK1 Flexible Bronchoscope Z21493US-BA (06/2019)

    Failure to achieve the expected six-log reduction in microorganisms following the disinfection process.

    FDA · DeviceKarl Storz EndoscopyU.S. Nationwide distribution in the states of FL, KY, LA, MA, MI, MO, MT, NC,…Official notice →
  4. US
    Drugs & medicalClass II

    Ethicon, Inc. recalls STRATAFIX SPIRAL PGA-PCL UNI UD sizes: [20CM USP2-0(M3) S/A RB-1, product code: SXMD1B403-12] and [30CM USP2-0(M3) S/A PS-1, product code:…

    Affected product lots may contain the incorrect needle type/size and suture length due to component mix-up.

    FDA · DeviceEthicon, Inc.International distribution in the country of China.Official notice →
  5. US
    Drugs & medicalClass II

    ROi CPS LLC recalls Regard brand CABG Pack A and B - Spartanburg

    Kits were packed into shipping boxes incorrectly.

    FDA · DeviceROi CPS LLCRecall impacted one domestic consignee in NCOfficial notice →
  6. US
    Drugs & medicalClass II

    USA Medical, LLC recalls Diagnostic Kit SARS-cCo V Antigen Rapid Test

    COVID-19/SARS-CoV-2 Antigen Tests did not receive FDA Emergency Use Authorization, nor were the tests cleared or approved to be commercially distributed.

    FDA · DeviceUSA Medical, LLCU.S. Nationwide distribution in the states of CA, FL, IN, MD, MO, NJ, OK, and…Official notice →
  7. US
    Drugs & medicalClass II

    Olympus Corporation of the Americas recalls BF-3C160: EVIS EXERA Bronchovideoscope

    Bronchofiberscope Updated instructions on the use of certain chemicals to be used for reprocessing, conditions for ETO gas sterilization, rinsing steps after high-level disinfection, and a recommendation on using…

    FDA · DeviceOlympus Corporation of the AmericasUS Nationwide distribution.Official notice →
See all drugs & medical recalls →